LEADER 01120nam  2200349Ia 450 
001 9910697093603321
005 20230902161551.0
035   $a(CKB)5470000002383962
035   $a(OCoLC)587369776
035   $a(EXLCZ)995470000002383962
100   $a20100330d1997      ua             0
101 0 $aeng
135   $auran|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aSUPAC-IR questions and answers about SUPAC-IR guidance$b[electronic resource]
210  1$a[Rockville, Md.] :$cFood and Drug Administration,$d[1997]
215   $a1 online resource
300   $a"February 18, 1997."
517 2 $aScale-up, post-approval changes, immediate release
606   $aSolid dosage forms$zUnited States
606   $aDrug development$zUnited States
615  0$aSolid dosage forms
615  0$aDrug development
712 02$aUnited States.$bFood and Drug Administration.
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910697093603321
996   $aSUPAC-IR questions and answers about SUPAC-IR guidance$93169178
997   $aUNINA